# DESCRIPTION

- government rights statement

## BACKGROUND OF THE INVENTION

- motivate targeted mutagenesis
- limitations of current methods

## BRIEF SUMMARY OF THE INVENTION

- introduce invention
- describe advantage of invention
- define sequence identity
- explain method to determine sequence identity
- provide examples of programs to determine sequence identity
- define sequence homology
- explain method to determine sequence homology
- define conservative substitution
- describe immunogenic composition
- list components of immunogenic composition
- define adjuvants
- list examples of adjuvants
- describe preferred amount of adjuvants
- define pharmaceutical-acceptable carrier
- describe administration of immunogenic composition
- provide examples of amounts of immunogenic composition
- describe combination vaccine or immunogenic composition
- list examples of further pathogens
- describe additional components of immunogenic composition
- introduce immunogenic composition administration
- motivate immune stimulant use
- describe allelic exchange method
- summarize Rickettsiales and Chlamydiales mutation
- describe targeted gene disruption
- describe gene function restoration
- provide Ehrlichia species examples
- describe targeted gene disruption in Ehrlichia
- describe immunogenic composition administration
- describe immunogenic composition components
- describe administration routes
- describe administration timing
- describe immunogenic composition effects
- describe Rickettsiale or Chlamydiale bacteria selection
- describe targeted allelic exchange mutation
- describe immunogenic composition administration method

## DETAILED DESCRIPTION OF THE INVENTION

- provide immunogenic bacteria method
- describe immunogenic composition or vaccine
- outline method for preventing or treating diseases
- outline method for reducing clinical symptoms
- specify recipient of product and method
- define modified or modified live nucleotide sequence
- explain nucleotide, polynucleotide or nucleic acid sequence
- distinguish from natural genomic nucleotide sequences
- describe construction of attenuated modified live vaccine
- detail experimental methods for creating targeted mutations
- clarify patentable scope of invention

## EXAMPLES

### Example 1

- cultivate E. chaffeensis
- construct homologous recombination plasmids
- prepare allelic exchange mutagenesis constructs
- purify cell-free E. chaffeensis organisms
- transform E. chaffeensis and isolate mutants
- confirm presence of mutants by genomic DNA analysis
- perform RNA analysis by RT-PCR
- verify loss and restoration of transcription
- describe Ech_0379 gene function rescue template
- construct Ech_0379 rescue plasmid
- generate linear fragments for allelic exchange mutagenesis
- perform Southern blot analysis

### Example 2

- cultivate E. canis and A. phagocytophilum
- construct homologous recombination plasmids
- purify cell-free E. canis and A. phagocytophilum organisms
- transform E. canis and A. phagocytophilum and isolate mutants
- confirm presence of mutants by genomic DNA analysis

### Example 3

- describe in vitro cultivation and cell-free E. chaffeensis recovery
- outline bacterial mRNA enrichment and sequencing
- summarize bioinformatics analysis
- describe quantitative real-time reverse transcription PCR
- introduce Ehrlichia chaffeensis and its pathogenesis
- motivate studying mutations in E. chaffeensis
- describe previous studies on E. chaffeensis mutations
- outline the current study's objectives
- describe the selection of mutants for RNA sequencing
- discuss the importance of high-throughput RNA sequencing
- summarize the challenges of isolating Ehrlichia RNA from host cells
- describe the cell lysis strategy and density gradient centrifugation
- outline the enrichment of Ehrlichia RNA and removal of host RNA
- summarize the results of isolating and purifying cell-free E. chaffeensis
- introduce RNA seq data of E. chaffeensis wildtype and mutants
- describe transcriptome data analysis
- summarize global transcriptome of E. chaffeensis
- describe differential gene expression in ECH_0379 mutant
- identify downregulated genes in ECH_0379 mutant
- identify upregulated genes in ECH_0379 mutant
- describe differential gene expression in ECH_0490 mutant
- identify downregulated genes in ECH_0490 mutant
- identify upregulated genes in ECH_0490 mutant
- describe differential gene expression in ECH_0660 mutant
- identify differentially expressed genes in ECH_0660 mutant
- validate RNA seq data by qRT-PCR
- discuss challenges in transcriptional profiling of intracellular pathogens
- describe method for isolation and purification of host cell-free E. chaffeensis organisms
- discuss impact of mutations on E. chaffeensis transcription
- describe highly expressed genes in E. chaffeensis
- discuss role of T4SS effector proteins in pathogenicity
- describe stress response proteins in E. chaffeensis
- discuss hypothetical protein genes in E. chaffeensis
- describe antiporter and transport proteins in E. chaffeensis
- discuss metabolic depression in ECH_0379 mutant
- discuss implications of transcriptome changes on pathogen's survival and virulence

## CONCLUSIONS

- summarize RNA seq study findings

